Biden Administration Supports Waiver of IP Protection for COVID-19 Vaccines

Publication Date06 May 2021
SubjectWTO,Vaccinations,TRIPS Agreement,Intellectual Property Protection,Pharmaceutical Industry,Coronavirus/COVID-19,Biden Administration
AuthorDonald Zuhn
Law FirmMcDonnell Boehnen Hulbert & Berghoff LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT